latest news: Pharmaceuticals
Showing 10 of 74 Articles:
-
Newly developed molecule to improve pharmaceuticals draws inspiration from nature’s toolbox
However, there is only one fluorination reaction known to occur in nature. And this process is performed by complex and highly specialized enzymes that are difficult to replicate. Now, scientists have developed a new, streamlined molecule that can do the work of enzymes but be designed and controlled minutely. This new catalyst transforms a safe, […]
Pharmaceuticals -
Aryl C–H bonds succumb to fluorination
Transition-metal-fluoride electrophile reacts with druglike molecules A general and mild method for turning aromatic C–H bonds into C–F bonds offers chemists a way to create fluorinated molecules that were difficult to make before. Because the chemistry tolerates a broad range of functional groups, it can fluorinate molecules in the later stages of a chemical synthesis—to […]
International Pharmaceuticals -
Cerecor to Acquire Avadel Pharmaceuticals’ Pediatric Assets
Excerpts: Cerecor, Inc. (NASDAQ: CERC) today announced it has entered into definitive agreements with Avadel U.S. Holdings, Inc., and certain of its subsidiaries, to purchase and acquire all rights to Avadel’s marketed pediatric products. The acquired products consist of Karbinal™ ER, AcipHex® Sprinkle™, Cefaclor for Oral Suspension, and Flexichamber™. Additionally, Avadel Ireland will develop and […]
United States, National USA Pharmaceuticals -
Garlic and fluorine show drug delivery promise
A new study has reported success, in terms of drug delivery, with the unusual combination of garlic and fluorine. This partly relates to garlic’s use as a traditional medicine. It’s the case of ancient medicine meeting modern technology. For centuries the allium root vegetable garlic has been used as a medicine, from the times of […]
United States, National USA Pharmaceuticals -
Fluoride Supplements & Vitamins: Cerecor Acquires TRx Pharmaceuticals
BALTIMORE, MD–(Marketwired – November 17, 2017) – Cerecor Inc. (NASDAQ: CERC) and TRx Pharmaceuticals, LLC (TRx) today announced that the companies have entered into a purchase agreement in which Cerecor will acquire TRx, including subsidiary Zylera Pharmaceuticals, LLC and its franchise of commercial medications led by Poly-Vi-Flor® (multivitamin and fluoride supplement tablet, chewable) and Tri-Vi-Flor® […]
United States, National USA Pharmaceuticals -
Osaka University chemists unlock the potential of fluoroalkenes
One of the strongest chemical bonds in organic chemistry is formed between carbon and fluorine, giving unique properties to chemical compounds featuring this group. Pharmaceutical researchers are very interested in carbon-fluorine bond containing molecules because of the way they mimic certain behaviors of biological compounds. However, the strength of the carbon-fluorine bond makes it difficult […]
International Chemical Industry Pharmaceuticals -
The Science of Fluoride Flipping
Chapel Hill, NC — So much of what happens inside cells to preserve health or cause disease is so small or time-sensitive that researchers are just now getting glimpses of the complexities unfolding in us every minute of the day. UNC School of Medicine researchers have discovered one such complexity — a previously hidden mode […]
International Pharmaceuticals -
FDA issues warning after skin cancer cream reportedly killed 5 dogs
The U.S. Food and Drug Administration (FDA) recently issued a warning that affects those who have pets and use a particular variety of topical cancer medication. According to the FDA, “pets are at risk of illness and death when exposed to the topical cancer medication Fluorouracil Cream USP 5%…intended for use in people. Fluorouracil may […]
Pharmaceuticals -
Endo Pharmaceuticals, Inc. Proposed Class Action Settlement for Persons and Entities Who Purchased and/or Paid for Multi-Vitamin with Fluoride Chewable Tablets
If You Purchased and/or Paid for Multi-Vitamin with Fluoride Chewable Tablets You Could Get Money from a Proposed Class Action Settlement A Settlement has been reached in a class action lawsuit involving Multi-Vitamin with Fluoride Chewable Tablets made by Endo Pharmaceuticals, Inc., and its subsidiaries (the “Chewable Tablets”). The lawsuit claims that the labels and […]
United States, National USA Pharmaceuticals -
Endo To Pay $15.5M to Settle Fluoride Multivitamin Class Action
Endo Health Solutions Inc. has reportedly agreed to pay $15.5 million to settle a class action lawsuit over its Qualitest multivitamins that allegedly contain less than 45 percent of the amount of fluoride that is advertised on the label. Plaintiff Shannon Mahoney initially filed the Endo class action lawsuit in December 2015, alleging she purchased […]
United States, National USA Pharmaceuticals